Answers are grounded in this paper and cite their sources.
Findings suggest that GCBT may yield a positive impact on more dimensions of dyspareunia than a topical steroid, and support its recommendation as a first-line treatment for provoked vestibulodynia.
No takes yet. Share an insight, caveat, or question.
Bergeron et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: